Cullin3 mitigates NEFA-induced oxidative stress in mammary epithelial cells: involvement of BCL2/BECN1 and autophagy.

J Dairy Sci

State Key Laboratory for Diagnosis and Treatment of Severe Zoonotic Infectious Diseases, Key Laboratory for Zoonosis Research of the Ministry of Education, Institute of Zoonosis, and College of Veterinary Medicine, Jilin University, Changchun 130062, China. Electronic address:

Published: March 2025

High nonesterified fatty acid (NEFA) concentrations in cows with clinical ketosis lead to metabolic dysfunction in mammary cells, resulting in oxidative stress. Studies have shown that autophagy is impaired in the mammary glands of ketotic cows, while enhancing autophagy mitigate oxidative stress in these animals. Cullin3 (CUL3), an E3 ubiquitin ligase, is integral for maintaining cellular homeostasis, particularly regulation of oxidative stress and autophagy. Whether CUL3 is involved in mitigating NEFA-induced oxidative stress is unknown. This study aimed to investigate the protective effects and underlying mechanisms whereby CUL3 mitigates NEFA-induced oxidative stress in mammary epithelial cells. First, mammary gland tissue and blood samples were collected from healthy cows [n = 12, β-hydroxybutyrate (BHB) < 0.6 mM] and cows with clinical ketosis (n = 12, BHB > 3.0 mM). Compared with healthy cows, cows with clinical ketosis had reduced productive performance, decreased CUL3 expression, impaired autophagic activity, and increased oxidative stress status in mammary tissue. In vitro, incubating MAC-T with 1.2 mM NEFA downregulated CUL3 expression, impaired autophagy, and increased oxidative stress. Adenovirus-mediated overexpression of CUL3 attenuated NEFA-induced accumulation of peroxides and reactive oxygen species (ROS), while silencing of CUL3 via siRNA exacerbated these effects. Even when nuclear factor erythroid 2 related factor 2 (NFE2L2) expression was reduced by overexpression of CUL3, there was no worsening of NEFA-induced reductions in mRNA levels of NFE2L2 downstream target genes [NADPH quinone oxidoreductase 1 (NQO1), Heme oxygenase-1 (HMOX1), Glutamate-cysteine ligase catalytic (GCLC) and Glutamate cysteine ligase modifier subunit (GCLM)]. The reduction in NEFA-induced oxidative stress by CUL3 was diminished upon autophagy related 5 (ATG5) silencing suggesting that CUL3 alleviates NEFA-induced oxidative stress via autophagy. Additionally, CUL3 overexpression aggravated the NEFA-induced decrease in BCL2 apoptosis regulator (BCL2) expression while alleviating the NEFA-induced decrease in beclin1(BECN1) expression. Under NEFA treatment, overexpression of BCL2 partly mitigated the CUL3-induced elevation in BECN1. Overall, oxidative stress and impaired autophagy characterize mammary tissue of cows with clinical ketosis. CUL3 activation, likely through the BCL2-BECN1 pathway, enhances autophagy and mitigates NEFA-induced oxidative stress in MAC-T cells. Thus, targeting CUL3-mediated autophagy could be a promising therapeutic strategy to reduce oxidative stress-induced damage in bovine mammary epithelial cells.

Download full-text PDF

Source
http://dx.doi.org/10.3168/jds.2024-25879DOI Listing

Publication Analysis

Top Keywords

oxidative stress
48
nefa-induced oxidative
24
cows clinical
16
clinical ketosis
16
oxidative
13
mitigates nefa-induced
12
stress
12
mammary epithelial
12
epithelial cells
12
cul3
12

Similar Publications

Endometriosis and cancer risk.

Eur J Cancer Prev

March 2025

Department of Oncology and Hemato-Oncology, University of Milan.

Endometriosis is one of the most common gynecological benign disease. Epidemiological evidence suggests a potential association between endometriosis and cancer risk. Accumulating evidence highlighted the risk of ovarian cancer, particularly endometrioid and clear cell subtypes.

View Article and Find Full Text PDF

UCNPs@PVP-Hemin-GOx@CaCO Nanoplatform for Ferroptosis Self-Amplification Combined with Calcium Overload.

Adv Healthc Mater

March 2025

Molecular Diagnostic Center, Key Laboratory of Clinical Cancer Pharmacology and Toxicology Research of Zhejiang Province, Hangzhou First People's Hospital, Hangzhou, 310006, China.

Due to the complexity of the tumor microenvironment (TME), current tumor treatments cannot achieve satisfactory results. A nanocomposite material, UCNPs@PVP-Hemin-GOx@CaCO (UPHGC NPs) is developed that responds to the TME and controls release to achieve multimodal synergistic therapy in tumor tissues. UPHGC NPs mediate photodynamic therapy (PDT), chemodynamic therapy (CDT), and starvation therapy (ST) synergistically, ultimately inducing self-amplification of ferroptosis.

View Article and Find Full Text PDF

Enhanced Tumor Ablation and Immune Activation Via Irreversible Electroporation and Functionalized Vermiculite Nanosheets.

Small

March 2025

State Key Laboratory of Advanced Medical Materials and Devices, Medical College, Tianjin University, Tianjin, 300072, China.

Irreversible electroporation (IRE) is a minimally invasive, non-thermal tumor ablation technique that induces nanoscale membrane perforation, leading to immunogenic cell death (ICD). However, IRE alone is limited by uneven electric field attenuation, incomplete tumor ablation, and the immunosuppressive nature of the tumor microenvironment. To address these challenges, a multifunctional nanomaterial, vermiculite nanosheets/calcium peroxide nanosheets (VMT/CaO NSs), is developed to enhance the efficacy of IRE.

View Article and Find Full Text PDF

Rational Fabrication of Copper Nanoclusters and In Vitro Study of Antioxidant Property.

Nanomaterials (Basel)

February 2025

School of Chemistry and Materials Science, Hangzhou Institute for Advanced Study, University of Chinese Academy of Sciences, 1 Sub-Lane Xiangshan, Hangzhou 310024, China.

Oxidative stress, resulting from an imbalance between reactive oxygen species (ROS) and antioxidants, is a critical factor in the pathogenesis of a wide range of diseases. The excessive accumulation of ROS can cause severe cellular damage, leading to tissue dysfunction and disease progression. The development of nanomaterials with antioxidant properties presents a promising strategy for addressing this challenge.

View Article and Find Full Text PDF

Acute myocardial infarction, a leading cause of death globally, is often associated with cardiometabolic disorders such as atherosclerosis and metabolic syndrome. Metabolic treatment of these disorders can improve cardiac outcomes, as exemplified by the GLP-1 agonist semaglutide. Fibroblast growth factor 21 (FGF21), a novel metabolic regulator, plays pivotal roles in lipid mobilization and energy conversion, reducing lipotoxicity, inflammation, mitochondrial health, and subsequent tissue damage in organs such as the liver, pancreas, and heart.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!